Suppr超能文献

[2021年哥伦比亚80岁及以上人群接种新冠疫苗的意愿]

[Willingness to receive the COVID-19 vaccine in the population aged 80 years and older in Colombia 2021].

作者信息

Alvis-Guzman N, Alvis-Zakzuk J, Paz-Wilches J, Fernandez-Mercado J C, de la Hoz-Restrepo F

机构信息

Grupo de Investigación en Economía de la Salud, Universidad de Cartagena, Cartagena, Colombia.

Grupo de Investigación en Gestion Hospitalaria y Políticas de Salud, Universidad de la Costa-CUC, Barranquilla, Colombia.

出版信息

Vacunas. 2022 May;23:S41-S45. doi: 10.1016/j.vacun.2021.07.005. Epub 2021 Aug 4.

Abstract

OBJECTIVE

Colombia designed and adopted a vaccination plan against COVID-19 that will immunize 35 million people. The aim study was to know the willingness to accept the vaccination against COVID-19.

METHODS

A telephone survey of 11,721 people aged 80 and over, affiliated with a health insurer, was carried. The respondents were the affiliates or their relatives or caregivers.

RESULTS

The average age was 85.0 years (SD: 4.5), with no differences between sexes; 3,344 (28.5%) referred a previous diagnostic test for COVID-19 and 73 were positive for an incidence of 622.8 per 100,000 people (95%CI: 491-778). Regarding the attitude with the vaccination against SARS-CoV-2, 1/4 respondents refrained from giving an opinion or was neutral. When the respondent was a relative, the acceptance of the vaccine was 60.4% (95% CI: 59.5-61.3) with differences by gender: men 62.2% (95% CI: 60.8-63.6) and women of 59.2 (95% CI: 58.0-60.3),  < 0.05. When the respondent was the potential recipient of the vaccine, the acceptance of the vaccine was 61.7% (95% CI: 59.4-64.0) and also differed by gender: 70.2% in men (95% CI: 66, 9-73.5) and 55.1% in women (95% CI: 52.0-58.3),  < 0.05.

CONCLUSION

The relatively low acceptance of vaccination against COVID-19 in Colombia poses significant challenges to achieve herd immunity that allows control of the pandemic.

摘要

目的

哥伦比亚设计并采用了一项针对新冠病毒的疫苗接种计划,该计划将为3500万人接种疫苗。本研究旨在了解人们接受新冠病毒疫苗接种的意愿。

方法

对11721名80岁及以上加入健康保险公司的人群进行了电话调查。受访者为参保人本人、其亲属或护理人员。

结果

平均年龄为85.0岁(标准差:4.5),男女之间无差异;3344人(28.5%)曾接受过新冠病毒诊断检测,其中73人呈阳性,发病率为每10万人622.8例(95%置信区间:491 - 778)。关于对新冠病毒疫苗接种的态度,四分之一的受访者未发表意见或持中立态度。当受访者为亲属时,疫苗接种接受率为60.4%(95%置信区间:59.5 - 61.3),存在性别差异:男性为62.2%(95%置信区间:60.8 - 63.6),女性为59.2%(95%置信区间:58.0 - 60.3),P<0.05。当受访者为疫苗潜在接种对象时,疫苗接种接受率为61.7%(95%置信区间:59.4 - 64.0),也存在性别差异:男性为70.2%(95%置信区间:66.9 - 73.5),女性为55.1%(95%置信区间:52.0 - 58.3),P<0.05。

结论

哥伦比亚对新冠病毒疫苗接种的接受率相对较低,这对实现群体免疫以控制疫情构成了重大挑战。

相似文献

9
Acceptance of the COVID-19 Vaccine by Foreigners in South Korea.韩国外国人对 COVID-19 疫苗的接受程度。
Int J Environ Res Public Health. 2021 Nov 16;18(22):12035. doi: 10.3390/ijerph182212035.

引用本文的文献

本文引用的文献

2
A global survey of potential acceptance of a COVID-19 vaccine.一项针对 COVID-19 疫苗潜在接受度的全球调查。
Nat Med. 2021 Feb;27(2):225-228. doi: 10.1038/s41591-020-1124-9. Epub 2020 Oct 20.
3
Determinants of COVID-19 vaccine acceptance in the US.美国新冠疫苗接种意愿的影响因素
EClinicalMedicine. 2020 Sep;26:100495. doi: 10.1016/j.eclinm.2020.100495. Epub 2020 Aug 12.
6
The value of vaccination.疫苗接种的价值。
Adv Exp Med Biol. 2011;697:1-8. doi: 10.1007/978-1-4419-7185-2_1.
7
The value of vaccination: a global perspective.疫苗接种的价值:全球视角
Vaccine. 2003 Oct 1;21(27-30):4105-17. doi: 10.1016/s0264-410x(03)00377-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验